Urinary Bladder Biopsy Diagnostic Requirements For Appropriate Patient Management - ICD-10-CM Quality Payment Program Measure

Quality Measure Description High Priority Submission Methods
Urinary Bladder Biopsy Diagnostic Requirements For Appropriate Patient ManagementPercentage of urinary bladder carcinoma pathology reports that include the procedure, histologic tumor grade, histologic type, muscularis propria presence, presence/absence of lymphovascular invasion and tumor extent. AND meet the maximum 2 business day turnaround time (TAT) requirement (Report Date – Accession Date is less than or equal to 2 business days). INSTRUCTIONS: This measure has two performance rates that contribute to the overall performance score: 1. Percent of cases for which all required data elements of the urinary bladder carcinoma pathology report are included. 2. Percent of cases that meet the maximum 2 business day turnaround time. The overall performance score submitted is a weighted average of: (Performance rate 1 x 70%)+(Performance rate 2 x 30%)YESRegistry

Linked ICD-10 Codes

The following ICD-10-CM codes are linked to the quality measure urinary bladder biopsy diagnostic requirements for appropriate patient management when used as part of a patient's medical record. This Quality Measure is part of Medicare's Quality Payment Program (QPP).

ICD CodeDescriptionCategory

View All Quality Payment Program Measures